These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 12388999

  • 1. Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia.
    Roes EM, Sweep CG, Thomas CM, Zusterzeel PL, Geurts-Moespot A, Peters WH, Steegers EA.
    Am J Obstet Gynecol; 2002 Oct; 187(4):1019-25. PubMed ID: 12388999
    [Abstract] [Full Text] [Related]

  • 2. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
    Nakashima A, Kobayashi T, Terao T.
    Gynecol Obstet Invest; 1996 Oct; 42(2):95-101. PubMed ID: 8878712
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activators and plasminogen activator inhibitors in plasma of premature and term newborns.
    Astedt B, Lindoff C.
    Acta Paediatr; 1997 Jan; 86(1):111-3. PubMed ID: 9116413
    [Abstract] [Full Text] [Related]

  • 4. Increased blood flow resistance in placental circulation and levels of plasminogen activator inhibitors types 1 and 2 in severe preeclampsia.
    He S, Bremme K, Blombäck M.
    Blood Coagul Fibrinolysis; 1995 Dec; 6(8):703-8. PubMed ID: 8825219
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activator of urokinase type and its inhibitor of placental type in hypertensive pregnancies and in intrauterine growth retardation: possible markers of placental function.
    Lindoff C, Astedt B.
    Am J Obstet Gynecol; 1994 Jul; 171(1):60-4. PubMed ID: 8030735
    [Abstract] [Full Text] [Related]

  • 6. Coagulation and fibrinolysis in preeclampsia and neonates.
    Tanjung MT, Siddik HD, Hariman H, Koh SC.
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):467-73. PubMed ID: 16244774
    [Abstract] [Full Text] [Related]

  • 7. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
    Coolman M, de Groot CJ, Steegers EA, Geurts-Moespot A, Thomas CM, Steegers-Theunissen RP, Sweep FC.
    Eur J Obstet Gynecol Reprod Biol; 2006 Oct; 128(1-2):22-8. PubMed ID: 16584829
    [Abstract] [Full Text] [Related]

  • 8. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
    Catarino C, Rebelo I, Belo L, Rocha S, Castro EB, Patricio B, Quintanilha A, Santos-Silva A.
    Thromb Res; 2008 Oct; 123(2):219-24. PubMed ID: 18384840
    [Abstract] [Full Text] [Related]

  • 9. Decreased endothelial progenitor cells in umbilical cord blood in severe preeclampsia.
    Kwon JY, Maeng YS, Kwon YG, Kim YH, Kang MH, Park YW.
    Gynecol Obstet Invest; 2007 Oct; 64(2):103-8. PubMed ID: 17339774
    [Abstract] [Full Text] [Related]

  • 10. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia.
    Koh SC, Anandakumar C, Montan S, Ratnam SS.
    Gynecol Obstet Invest; 1993 Oct; 35(4):214-21. PubMed ID: 8330765
    [Abstract] [Full Text] [Related]

  • 11. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia.
    Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J.
    Br J Obstet Gynaecol; 1994 Jun; 101(6):488-92. PubMed ID: 8018635
    [Abstract] [Full Text] [Related]

  • 12. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.
    Estellés A, Gilabert J, España F, Aznar J, Galbis M.
    Am J Obstet Gynecol; 1991 Jul; 165(1):138-42. PubMed ID: 1906680
    [Abstract] [Full Text] [Related]

  • 13. Fibrinolysis parameters in Sudanese women with severe preeclampsia.
    Elzein HO, Muddathir AR, Rida M, Rayis DA, Elhassan EM, Adam I.
    Hypertens Pregnancy; 2016 Nov; 35(4):559-564. PubMed ID: 27598010
    [Abstract] [Full Text] [Related]

  • 14. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC, Neveu S, Mares P, Biron C, Hedon B, Schved JF.
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [Abstract] [Full Text] [Related]

  • 15. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation.
    Schjetlein R, Haugen G, Wisløff F.
    Acta Obstet Gynecol Scand; 1997 Jul; 76(6):541-6. PubMed ID: 9246959
    [Abstract] [Full Text] [Related]

  • 16. Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy.
    Astedt B, Lindoff C, Lecander I.
    Semin Thromb Hemost; 1998 Jul; 24(5):431-5. PubMed ID: 9834009
    [Abstract] [Full Text] [Related]

  • 17. Comparison of maternal and umbilical cord blood HIF-1α and nitric oxide levels in early and late onset preeclamptic pregnancies.
    Demircan Sezer S, Küçük M, Nergiz Avcıoğlu S, Zafer E, Altınkaya SÖ, Bıçakçı B, Yenisey Ç, Yüksel H, Kurt Ömürlü İ.
    Gynecol Endocrinol; 2015 Jul; 31(12):945-8. PubMed ID: 26172929
    [Abstract] [Full Text] [Related]

  • 18. Maternal plasma plasminogen activator inhibitor-2 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy.
    Akolekar R, Cruz Jde J, Penco JM, Zhou Y, Nicolaides KH.
    Hypertens Pregnancy; 2011 Jul; 30(2):194-202. PubMed ID: 20205627
    [Abstract] [Full Text] [Related]

  • 19. Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia.
    Wikström AK, Nash P, Eriksson UJ, Olovsson MH.
    Am J Obstet Gynecol; 2009 Dec; 201(6):597.e1-8. PubMed ID: 19683696
    [Abstract] [Full Text] [Related]

  • 20. Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies.
    Dong YL, Chauhan M, Green KE, Vegiraju S, Wang HQ, Hankins GD, Yallampalli C.
    Am J Obstet Gynecol; 2006 Dec; 195(6):1657-67. PubMed ID: 16996466
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.